Study Confirms Efficacy of Upstream Peripheral’s GoBack Catheter

Upstream Peripheral Technologies is touting clinical results for its GoBack Catheter.

A study published in the Journal of Endovascular Therapy found the catheter effective for crossing and re-entry in patients undergoing complex revascularizations in lower limb arteries. “All patients should have access to the most effective endovascular revascularization technologies to avoid unnecessary bypass surgeries and amputations,” said Dani Rottenberg, founder and CEO of Upstream. “The GoBack helps clinicians achieve such a goal, especially in more complex lesions.”

The GoBack Catheter is a single-lumen crossing catheter which features a curved nitinol needle that serves as an effective crossing tool. The versatile needle can be extended straight or to a curved position beyond the GoBack Catheter’s tip. The protrusion length is determined by the clinician with a thumb selector on the device’s handle. The GoBack comes in configurations of 4 French and 2.9 French for above and below the knee procedures. The product is approved for use in 30 countries.
 
In a single-center retrospective study led by Professor Andrej Schmidt (University Hospital, Leipzig), researchers reviewed outcomes of 100 consecutive patients who underwent treatment with the GoBack Catheter after failed crossing attempts using standard guidewire and support catheter techniques. All lesions were confirmed as either de-novo or re-occluded chronic total occlusions (CTO). The overall technical success rate was 92 percent.
 
The study highlights the versatility and effectiveness of the GoBack Catheter as both a crossing and reentry tool when compared to alternative products. In addition, the study further outlines the clinical benefits of the GoBack Catheter with its robust, retractable needle at its tip. 
 
“The GoBack helps facilities manage their costs and maximize their lab optimization by reducing procedure time and using less consumables per procedure,” Rottenberg said. 
 
Upstream Peripheral Technologies, a privately-held company, produces the GoBack Catheter to treat chronic total occlusions in angioplasty procedures.